Key result
RVPA shunt in the Norwood procedure is linked to ~63% lower 2-year mortality than MBTS.
Why the study?
Does the RVPA shunt improve 2-year survival and psychomotor outcomes compared to the MBTS shunt in neonates undergoing the Norwood procedure for hypoplastic left heart syndrome?
Population
94 neonates with hypoplastic left heart syndrome undergoing the Norwood procedure
Comparison
Norwood procedure with right… vs Norwood procedure with modified Blalock-Taussig…
Design
Cohort
Follow-up
2 years
Authors
Loading...
The use of the RVPA shunt during the Norwood procedure for hypoplastic left heart syndrome is associated with improved 2-year survival and psychomotor development compared to the historical MBTS shunt.
Cohort (n=94)
No
Does the RVPA shunt improve 2-year survival and psychomotor outcomes compared to the MBTS shunt in neonates undergoing the Norwood procedure for hypoplastic left heart syndrome?
Absolute Event Rate: 19% vs 52%
p-value: p=0.002
The use of the RVPA shunt during the Norwood procedure for hypoplastic left heart syndrome is associated with improved 2-year survival and psychomotor development compared to the historical MBTS shunt.
Atallah et al. (2008) conducted a cohort in hypoplastic left heart syndrome (n=94). Norwood procedure with right ventricle-to-pulmonary artery (RVPA) shunt vs. Norwood procedure with modified Blalock-Taussig (MBTS) shunt was evaluated on 2-year mortality rate (p=0.002). The Norwood procedure using the RVPA shunt was associated with a lower 2-year mortality rate (19% vs 52%, P=0.002) and improved psychomotor development compared to the MBTS shunt.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: